Literature DB >> 10918053

HCaRG, a novel calcium-regulated gene coding for a nuclear protein, is potentially involved in the regulation of cell proliferation.

N Solban1, H P Jia, S Richard, S Tremblay, A M Devlin, J Peng, F Gossard, D F Guo, G Morel, P Hamet, R Lewanczuk, J Tremblay.   

Abstract

Since a negative calcium balance is present in spontaneously hypertensive rats, we searched for the gene(s) involved in this dysregulation. A cDNA library was constructed from the spontaneously hypertensive rat parathyroid gland, which is a key regulator of serum-ionized calcium. From seven overlapping DNA fragments, a 1100-base pair novel cDNA containing an open reading frame of 224 codons was reconstituted. This novel gene, named HCaRG (hypertension-related, calcium-regulated gene), was negatively regulated by extracellular calcium concentration, and its basal mRNA levels were higher in hypertensive animals. The deduced protein showed no transmembrane domain, 67% alpha-helix content, a mutated calcium-binding site (EF-hand motif), four putative "leucine zipper" motifs, and a nuclear receptor-binding domain. At the subcellular level, HCaRG had a nuclear localization. We cloned the human homolog of this gene. Sequence comparison revealed 80% homology between rats and humans at the nucleotide and amino acid sequences. Tissue distribution showed a preponderance in the heart, stomach, jejunum, kidney (tubular fraction), liver, and adrenal gland (mainly in the medulla). HCaRG mRNA was significantly more expressed in adult than in fetal organs, and its levels were decreased in tumors and cancerous cell lines. We observed that after 60-min ischemia followed by reperfusion, HCaRG mRNA declined rapidly in contrast with an increase in c-myc mRNA. Its levels then rose steadily to exceed base line at 48 h of reperfusion. HEK293 cells stably transfected with HCaRG exhibited much lower proliferation, as shown by cell count and [(3)H]thymidine incorporation. Taken together, our results suggest that HCaRG is a nuclear protein potentially involved in the control of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918053     DOI: 10.1074/jbc.M001352200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion.

Authors:  Bart van de Sluis; Xicheng Mao; Yali Zhai; Arjan J Groot; Jeroen F Vermeulen; Elsken van der Wall; Paul J van Diest; Marten H Hofker; Cisca Wijmenga; Leo W Klomp; Kathleen R Cho; Eric R Fearon; Marc Vooijs; Ezra Burstein
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  COMMD1 expression is controlled by critical residues that determine XIAP binding.

Authors:  Gabriel N Maine; Xicheng Mao; Patricia A Muller; Christine M Komarck; Leo W J Klomp; Ezra Burstein
Journal:  Biochem J       Date:  2009-01-15       Impact factor: 3.857

3.  A new locus for autosomal dominant amelogenesis imperfecta on chromosome 8q24.3.

Authors:  Gustavo Mendoza; Trevor J Pemberton; Kwanghyuk Lee; Raquel Scarel-Caminaga; Ruty Mehrian-Shai; Catalina Gonzalez-Quevedo; Vasiliki Ninis; Jaana Hartiala; Hooman Allayee; Malcolm L Snead; Suzanne M Leal; Sergio R P Line; Pragna I Patel
Journal:  Hum Genet       Date:  2006-09-21       Impact factor: 4.132

4.  HCaRG accelerates tubular repair after ischemic kidney injury.

Authors:  Hiroyuki Matsuda; Julie L Lavoie; Louis Gaboury; Pavel Hamet; Johanne Tremblay
Journal:  J Am Soc Nephrol       Date:  2011-09-15       Impact factor: 10.121

Review 5.  COMMD proteins: COMMing to the scene.

Authors:  G N Maine; E Burstein
Journal:  Cell Mol Life Sci       Date:  2007-08       Impact factor: 9.261

6.  Protective effects of medical ozone combined with traditional Chinese medicine against chemically-induced hepatic injury in dogs.

Authors:  Li-Jie Li; Yun-Gao Yang; Zhi-Ling Zhang; Sui-Feng Nie; Ze Li; Feng Li; He-Yu Hua; Yan-Jun Hu; Hong-Shuan Zhang; Ya-Bing Guo
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

7.  Decreased NKCC1 activity in erythrocytes from African Americans with hypertension and dyslipidemia.

Authors:  Sergei N Orlov; Francis Gossard; Zdenka Pausova; Olga A Akimova; Johanne Tremblay; Clarence E Grim; Jane M Kotchen; Theodore A Kotchen; Daniel Gaudet; Allen W Cowley; Pavel Hamet
Journal:  Am J Hypertens       Date:  2009-12-31       Impact factor: 2.689

8.  FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancer.

Authors:  S S Yang; X M Li; M Yang; X L Ren; J L Hu; X H Zhu; F F Wang; Z C Zeng; J Y Li; Z Q Cheng; W T Liao; Y Q Ding; J Guan; L Liang
Journal:  Br J Cancer       Date:  2017-08-17       Impact factor: 7.640

Review 9.  Hypertension-related, calcium-regulated gene (HCaRG/COMMD5) and kidney diseases: HCaRG accelerates tubular repair.

Authors:  Hiroyuki Matsuda; Pavel Hamet; Johanne Tremblay
Journal:  J Nephrol       Date:  2014-02-11       Impact factor: 3.902

10.  HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma.

Authors:  Hiroyuki Matsuda; Carole G Campion; Kyoko Fujiwara; Jin Ikeda; Suzanne Cossette; Thomas Verissimo; Maiko Ogasawara; Louis Gaboury; Kosuke Saito; Kenya Yamaguchi; Satoru Takahashi; Morito Endo; Noboru Fukuda; Masayoshi Soma; Pavel Hamet; Johanne Tremblay
Journal:  Oncotarget       Date:  2017-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.